000 03767nam a22004455i 4500
001 978-3-030-92938-1
003 DE-He213
005 20240729134813.0
007 cr nn 008mamaa
008 220217s2022 sz | s |||| 0|eng d
020 _a9783030929381
_9978-3-030-92938-1
024 7 _a10.1007/978-3-030-92938-1
_2doi
072 7 _aMJK
_2bicssc
072 7 _aMED017000
_2bisacsh
072 7 _aMJK
_2thema
245 1 0 _aBiologic Therapy for Psoriasis
_b : Cutting Edge Treatment Principles /
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _aXVII, 146 p. 5 illus., 4 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aUpdates in Clinical Dermatology,
_x2523-8892
505 0 _aIntroduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis.
520 _aBiologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies.
650 0 _aDermatology.
_95856
650 1 4 _aDermatology.
_95856
700 1 _aBrownstone, Nicholas.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBhutani, Tina.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aLiao, Wilson.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
830 0 _aUpdates in Clinical Dermatology,
_x2523-8892
856 _u#gotoholdings
_yAccess resource
912 _aZDB-2-SME
912 _aZDB-2-SXM
245 _h[E-Book]
999 _c102039
_d102039